| Cox HR (95% CI) |
---|---|
Primary end point | Â |
CV death, MI, stroke, or | 0.78 (0.55–1.12) |
UAP with hospitalization | Â |
Secondary end points | Â |
CV death, stroke, or MI | 0.74 (0.49–1.13) |
All major CV events | 0.82 (0.61–1.09) |
FDA-custom MACE | 0.70 (0.45–1.08) |
Tertiary end points | Â |
CV death | 1.04 (0.42–2.60) |
Non-fatal MI | 0.86 (0.47–1.56) |
Non-fatal stroke | 0.34 (0.15–0.75) |
TIA | 0.09 (0.01–0.75) |
UAP with hospitalization | 1.08 (0.56–2.06) |
Hospitalization for CHF* | 1.04 (0.43–2.47) |
Total mortality | 0.89 (0.45–1.75) |